Search research articles
Contact Us
Filters
Showing results (21-30 of 222) with videos related to
Page
of 23
Sort By:
Breast Cancer Research and Treatment
|
August 1, 2015
Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells
Rahul R Deshmukh, Q Ping Dou
Frontiers in Bioscience : a Journal and Virtual Library
|
March 17, 2005
The role of interleukin-2 receptor alpha in cancer
Deborah J Kuhn, Q Ping Dou
Current Cancer Drug Targets
|
August 6, 2014
Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system
Q Ping Dou, Jeffrey A Zonder
Idrugs : the Investigational Drugs Journal
|
June 13, 2003
Bortezomib (millennium pharmaceuticals)
Q Ping Dou, Ronald H Goldfarb
Current Drug Discovery Technologies
|
February 17, 2010
Targeting tumor proteasome with traditional Chinese medicine
Huanjie Yang, Jinbao Liu, Q Ping Dou
Journal of Cellular Physiology
|
March 31, 2011
Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli
Michael Frezza, Huanjie Yang, Q Ping Dou
Molecular Pharmacology
|
November 10, 2006
The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry"
Huanjie Yang, Guoqing Shi, Q Ping Dou
Frontiers in Molecular Biosciences
|
April 7, 2022
Editorial: Unravelling Copper-Regulatory Systems and Copper-Affected Pathways in Cancer Cells to Improve Current Therapies
Xin Chen, Chiara Nardon, Q Ping Dou
Current Topics in Medicinal Chemistry
|
August 10, 2011
Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy
Michael Frezza, Sara Schmitt, Q Ping Dou
Expert Opinion on Investigational Drugs
|
June 10, 2009
Clinical development of novel proteasome inhibitors for cancer treatment
Huanjie Yang, Jeffrey A Zonder, Q Ping Dou
Page
of 23
Search research articles
Search
Showing results (21-30 of 222) with videos related to
Sort By:
Page
of 23
Breast Cancer Research and Treatment
|
August 1, 2015
Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells
Rahul R Deshmukh, Q Ping Dou
Frontiers in Bioscience : a Journal and Virtual Library
|
March 17, 2005
The role of interleukin-2 receptor alpha in cancer
Deborah J Kuhn, Q Ping Dou
Current Cancer Drug Targets
|
August 6, 2014
Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system
Q Ping Dou, Jeffrey A Zonder
Idrugs : the Investigational Drugs Journal
|
June 13, 2003
Bortezomib (millennium pharmaceuticals)
Q Ping Dou, Ronald H Goldfarb
Current Drug Discovery Technologies
|
February 17, 2010
Targeting tumor proteasome with traditional Chinese medicine
Huanjie Yang, Jinbao Liu, Q Ping Dou
Journal of Cellular Physiology
|
March 31, 2011
Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli
Michael Frezza, Huanjie Yang, Q Ping Dou
Molecular Pharmacology
|
November 10, 2006
The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry"
Huanjie Yang, Guoqing Shi, Q Ping Dou
Frontiers in Molecular Biosciences
|
April 7, 2022
Editorial: Unravelling Copper-Regulatory Systems and Copper-Affected Pathways in Cancer Cells to Improve Current Therapies
Xin Chen, Chiara Nardon, Q Ping Dou
Current Topics in Medicinal Chemistry
|
August 10, 2011
Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy
Michael Frezza, Sara Schmitt, Q Ping Dou
Expert Opinion on Investigational Drugs
|
June 10, 2009
Clinical development of novel proteasome inhibitors for cancer treatment
Huanjie Yang, Jeffrey A Zonder, Q Ping Dou
Page
of 23